Detalhe da pesquisa
1.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
J Am Acad Dermatol
; 90(5): 986-993, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38253129
2.
INDIVIDUAL ARTICLE: Sugar Sag: What Is Skin Glycation and How Do You Combat It?
J Drugs Dermatol
; 23(4): SF378083s5-SF378083s10, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38564405
3.
INDIVIDUAL ARTICLE: Efficacy of a Prebiotic Skincare Regimen on Improving Mild Atopic Dermatitis and Severe Xerosis in Diverse Ethnically Patients.
J Drugs Dermatol
; 23(3): SF395747s12-SF395747s22, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38443135
4.
INDIVIDUAL ARTICLE: Atopic Dermatitis Skincare and Impact on Quality of Life for Patients with Skin of Color.
J Drugs Dermatol
; 23(3): SF395747s6-SF395747s11, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38443136
5.
A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen.
J Drugs Dermatol
; 23(4): 233-238, 2024 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38564394
6.
International Consensus on Anti-Aging Dermocosmetics and Skin Care for Clinical Practice Using the RAND/UCLA Appropriateness Method.
J Drugs Dermatol
; 23(1): 1337-1343, 2024 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38206152
7.
Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
N Engl J Med
; 383(3): 229-239, 2020 07 16.
Artigo
Inglês
| MEDLINE | ID: mdl-32668113
8.
Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.
Br J Dermatol
; 189(4): 392-399, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37279795
9.
DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial.
J Am Acad Dermatol
; 89(5): 945-951, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37295506
10.
Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials.
J Am Acad Dermatol
; 89(5): 927-935, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37656094
11.
Ceramide-Containing Adjunctive Skin Care for Skin Barrier Restoration During Acne Vulgaris Treatment.
J Drugs Dermatol
; 22(6): 554-558, 2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37276158
12.
Unmet Needs in the Management of Acne Vulgaris: A Consensus Statement.
J Drugs Dermatol
; 22(6): 582-587, 2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37276154
13.
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
J Drugs Dermatol
; 22(2): 139-147, 2023 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36745371
14.
Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
Pediatr Dermatol
; 40(3): 452-459, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36949579
15.
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Br J Dermatol
; 187(6): 878-887, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35986699
16.
Photoprotection for all: Current gaps and opportunities.
J Am Acad Dermatol
; 86(3S): S18-S26, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34942298
17.
Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel.
J Am Acad Dermatol
; 86(3S): S1-S8, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34942296
18.
Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study.
Dermatol Surg
; 48(1): 87-93, 2022 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34608092
19.
Vehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream.
J Drugs Dermatol
; 21(8): 875-880, 2022 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35946981
20.
SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene.
J Drugs Dermatol
; 21(12): SF3446185-SF34461814, 2022 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36468963